trehalose has been researched along with mk 2206 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajaj, L; Bondar, VV; Bremner, L; Chaudhury, A; Cooper, JD; Lotfi, P; Neilson, JR; Nelvagal, HR; Pal, R; Palmieri, M; Pautler, RG; Pereira, FA; Rodney, GG; Saleem, U; Sanagasetti, D; Sardiello, M; Seymour, ML; Stinnett, GR; Tse, DY; Wu, SM | 1 |
1 other study(ies) available for trehalose and mk 2206
| Article | Year |
|---|---|
mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases.
Topics: Animals; Astrocytes; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Brain; Cell Nucleus; Disease Models, Animal; Fibroblasts; Gene Knockdown Techniques; HeLa Cells; Heterocyclic Compounds, 3-Ring; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Membrane Glycoproteins; Mice; Mice, Transgenic; Molecular Chaperones; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Phosphorylation; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Signal Transduction; Trehalose | 2017 |